Safety and tolerability of SARS‐Cov‐2 vaccination in patients with myasthenia gravis: A multicenter experience-Reference-Cited by-同舟云学术

Safety and tolerability of SARS‐Cov‐2 vaccination in patients with myasthenia gravis: A multicenter experience

Published:2022-04-17 Issue:8 Volume:29 Page:2505-2510
ISSN:1351-5101
Container-title:European Journal of Neurology
language:en
Short-container-title:Euro J of Neurology

Author:

Farina Antonio¹^ORCID,Falso Silvia²,Cornacchini Sara¹,Spagni Gregorio²³,Monte Gabriele²^ORCID,Mariottini Alice¹⁴^ORCID,Massacesi Luca¹⁴,Barilaro Alessandro⁴,Evoli Amelia²³,Damato Valentina¹⁴^ORCID

Affiliation:

1. Department of Neurosciences, Drugs, and Child Health University of Florence Florence Italy

2. Department of Neuroscience Catholic University of the Sacred Heart Rome Italy

3. Neurology Unit Fondazione Policlinico Universitario “A. Gemelli” IRCCS Rome Italy

4. Department of Neurology 2 Careggi University Hospital Florence Italy

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ene.15348

Reference14 articles.

1. Heterogeneity in myasthenia gravis: considerations for disease management

2. Vaccination of patients with autoimmune inflammatory rheumatic diseases

3. A prospective, double-blind, randomized, placebo-controlled study on the efficacy and safety of influenza vaccination in myasthenia gravis

4. To Be or Not To Be Vaccinated: That Is a Question in Myasthenia Gravis

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient‐reported daily functioning after SARS‐CoV‐2 vaccinations in autoimmune neuromuscular diseases;European Journal of Neurology;2024-09-05

2. Predictive Factors for Poor Outcomes Associated with COVID-19 in a Retrospective Cohort of Myasthenia Gravis Patients;Journal of Inflammation Research;2024-08

3. COVID-19 in patients with myasthenia gravis: a single-center retrospective study in China;Neurological Sciences;2024-04-23

4. Identification of key genes as potential diagnostic and therapeutic targets for comorbidity of myasthenia gravis and COVID-19;Frontiers in Neurology;2024-02-07

5. Safety of SARS-CoV-2 vaccine in patients with autoimmune neurological conditions: A systematic review and meta-analysis;Heliyon;2024-01